John T. Schulz, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 8 | 2023 | 1848 | 0.640 |
Why?
|
| Thigh | 1 | 2016 | 240 | 0.490 |
Why?
|
| Hindlimb | 1 | 2002 | 508 | 0.180 |
Why?
|
| Skin, Artificial | 1 | 2000 | 89 | 0.160 |
Why?
|
| Burn Units | 3 | 2017 | 141 | 0.160 |
Why?
|
| Traumatology | 1 | 2018 | 94 | 0.140 |
Why?
|
| Shock, Hemorrhagic | 1 | 2018 | 223 | 0.130 |
Why?
|
| Critical Pathways | 1 | 2019 | 473 | 0.130 |
Why?
|
| Explosions | 1 | 2016 | 108 | 0.130 |
Why?
|
| Rehabilitation Centers | 1 | 2017 | 247 | 0.120 |
Why?
|
| Triage | 1 | 2019 | 986 | 0.100 |
Why?
|
| Emergencies | 1 | 2018 | 1209 | 0.100 |
Why?
|
| Societies, Medical | 2 | 2019 | 3891 | 0.080 |
Why?
|
| Sepsis | 1 | 2023 | 2587 | 0.080 |
Why?
|
| General Surgery | 1 | 2018 | 1677 | 0.070 |
Why?
|
| Skin | 1 | 2000 | 4464 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 2476 | 0.060 |
Why?
|
| Injury Severity Score | 2 | 2019 | 1033 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3446 | 0.060 |
Why?
|
| Spleen | 1 | 2010 | 2296 | 0.060 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 793 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2017 | 3245 | 0.050 |
Why?
|
| Patient Isolators | 1 | 2002 | 11 | 0.050 |
Why?
|
| Environment, Controlled | 1 | 2002 | 42 | 0.050 |
Why?
|
| Fires | 1 | 2004 | 169 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2002 | 365 | 0.050 |
Why?
|
| Length of Stay | 3 | 2023 | 6439 | 0.040 |
Why?
|
| Wound Infection | 1 | 2002 | 243 | 0.040 |
Why?
|
| Telemedicine | 1 | 2017 | 3018 | 0.040 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2002 | 244 | 0.040 |
Why?
|
| Skin Physiological Phenomena | 1 | 2000 | 188 | 0.040 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2002 | 586 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2002 | 1150 | 0.040 |
Why?
|
| Rabbits | 1 | 2002 | 4771 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2002 | 1846 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2017 | 176 | 0.030 |
Why?
|
| Standard of Care | 1 | 2019 | 550 | 0.030 |
Why?
|
| Trauma Severity Indices | 2 | 2010 | 478 | 0.030 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 388 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2002 | 1401 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2002 | 1688 | 0.030 |
Why?
|
| Cross Infection | 1 | 2002 | 1432 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 799 | 0.030 |
Why?
|
| Survivors | 1 | 2002 | 2371 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2002 | 2868 | 0.020 |
Why?
|
| Regeneration | 1 | 2000 | 1505 | 0.020 |
Why?
|
| Forecasting | 1 | 2000 | 2920 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 1067 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 1415 | 0.020 |
Why?
|
| Splenectomy | 1 | 2010 | 391 | 0.020 |
Why?
|
| Humans | 11 | 2023 | 758381 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2023 | 80170 | 0.020 |
Why?
|
| New England | 1 | 2010 | 1053 | 0.020 |
Why?
|
| Child | 4 | 2023 | 79813 | 0.020 |
Why?
|
| United States | 3 | 2019 | 72140 | 0.020 |
Why?
|
| Wound Healing | 1 | 2017 | 2783 | 0.020 |
Why?
|
| Trauma Centers | 1 | 2010 | 933 | 0.010 |
Why?
|
| Time Factors | 2 | 2002 | 39873 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2010 | 2640 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5484 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10719 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18357 | 0.010 |
Why?
|
| Chondroitin Sulfates | 1 | 2002 | 174 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7377 | 0.010 |
Why?
|
| Nails, Malformed | 1 | 2002 | 34 | 0.010 |
Why?
|
| Hospitals, Special | 1 | 2002 | 91 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 2004 | 408 | 0.010 |
Why?
|
| Adult | 5 | 2019 | 219916 | 0.010 |
Why?
|
| Resuscitation | 1 | 2004 | 661 | 0.010 |
Why?
|
| Boston | 2 | 2002 | 9304 | 0.010 |
Why?
|
| Eye Diseases | 1 | 2002 | 651 | 0.010 |
Why?
|
| Infection Control | 1 | 2002 | 982 | 0.010 |
Why?
|
| Female | 6 | 2017 | 390316 | 0.010 |
Why?
|
| Collagen | 1 | 2002 | 2635 | 0.010 |
Why?
|
| Male | 5 | 2017 | 358742 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2002 | 1088 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 6955 | 0.010 |
Why?
|
| Middle Aged | 3 | 2017 | 219560 | 0.010 |
Why?
|
| Critical Care | 1 | 2004 | 2692 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 167777 | 0.010 |
Why?
|
| Infant | 2 | 2002 | 36054 | 0.010 |
Why?
|
| Adolescent | 3 | 2002 | 87888 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2002 | 42058 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 10112 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 41252 | 0.000 |
Why?
|
| Comorbidity | 1 | 2002 | 10495 | 0.000 |
Why?
|
| Lung | 1 | 2004 | 9985 | 0.000 |
Why?
|
| Young Adult | 1 | 2010 | 58808 | 0.000 |
Why?
|
| Risk Factors | 1 | 2010 | 73806 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 39060 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 58681 | 0.000 |
Why?
|
| Aged | 1 | 2002 | 168217 | 0.000 |
Why?
|